Since imatinib preserves this important characteristic of normal vascular insulin sensitivity, and vascular insulin signaling plays an important role in the pathophysiology of type 2 diabetes and its complications [36], the anti-diabetic effect of imatinib might well be caused by its protective effect on this endothelial function. Here, INS is linked to type 2 diabetes mellitus.